AWM
MEDP icon

Apollon Wealth Management’s Medpace MEDP Stock Holding History

Apollon Wealth Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$346K Buy
653
+114
+21% +$52.6K ﹤0.01% 1189
2026
Q1 		$259K Buy
+539
New +$276K ﹤0.01% 1187
2024
Q3 		– Sell
-579
Closed -$238K – 1160
2024
Q2 		$238K Buy
579
+71
+14% +$28.1K 0.01% 943
2024
Q1 		$205K Buy
+508
New +$179K 0.01% 1029

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Apollon Wealth Management's MEDP Position: Q2 2026 in Review

Apollon Wealth Management increased its Medpace (MEDP) stake by 21% in Q2 2026, buying an estimated $52.6K and bringing the position to 653 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #1189.

Apollon Wealth Management first reported a position in MEDP in Q1 2024 and has held it in 4 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Apollon Wealth Management held 653 shares of Medpace worth $346K as of Q2 2026.
  • Apollon Wealth Management bought 114 Medpace shares in Q2 2026, an estimated $52.6K.
  • Medpace made up ﹤0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #1189 holding.
  • Apollon Wealth Management first reported a position in Medpace in Q1 2024 and has held it in 4 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.